FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Recruiting

Phase 1

PF-07832837FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Sponsor:

Pfizer

Code:

NCT06564389

Conditions

Healthy Participants

Atopic Dermatitis

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Accepted

Interventions

PF-07832837

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-11. This information was provided to ClinicalTrials.gov by Pfizer on 2025-08-15.